Skip to main content

Partial Win For Wright Medical in a Hip Implant Lawsuit

Partial Win For Wright Medical in a Hip Implant Lawsuit

Partial Win For Wright Medical in a Hip Implant Lawsuit

Introduction

Wright Medical Technology, Inc., named as the defendant in a hip implant lawsuit filed by a plaintiff, was granted a partial motion to dismiss a part of the plaintiff's complaint but denied the motion to strike her request for punitive damages and prejudgment interest. The order was released on November 5 and signed by U. S. District Judge Ted Stewart for the District of Utah.

The plaintiff filed the lawsuit alleging that she sustained injuries stemming from the defective hip implant devices manufactured and sold by Wright Medical Technology, Inc. Wright Medical Technology Inc., Conserve Hip Implant Products Liability Litigation  (MDL No. 2329), created in February 2012, was vacated by U.S. District Judge William S Duffey, Jr. in October 2017, as the purpose of a global resolution had been accomplished thereby allowing the direct filing of new cases. A final Master Settlement Agreement totaling $240 million was agreed as the settlement amount.

Zimmer Inc. and Stryker Corporation face similar allegations over their Hip implant products for causing internal complications due to the faulty design.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!